Rockwell heralds PhIII success for iron-delivery drug; Combined drugs could help treat HIV;

> Rockwell Medical ($RMTI) welcomed positive results in a Phase III study for its iron-delivery drug, showing the treatment increased hemoglobin in patients receiving hemodialysis. More

> Researchers at the University of Minnesota have developed a delivery system that combines two FDA-approved drugs that, together, could be an effective treatment for HIV. Story

> MusclePharm Corporation invested $2 million in BioZone, which has a drug delivery platform, QuSome, that enhances the absorption of topical and other drugs. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.